PAVmed Inc. (PAVM)

NCM – Цена в реальном времени. Валюта: USD

5.05

+0.70 (16.09%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

5.27

+0.22 (4.38%)

После закрытия: Jun 26, 2026, 7:29 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

PAVmed Inc. (PAVM)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

PAVmed Inc. (PAVM)

PAVmed Inc. (PAVM) Q1 2026 Earnings Call Transcript

PAVmed Inc. (PAVM) Reports Q1 Loss, Lags Revenue Estimates

PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results

Will PAVmed Inc. (PAVM) Report Negative Earnings Next Week? What You Should Know

Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026

Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock

Видео

No Data

Пресс-релизы

PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results

Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock

Search stocks

PAVmed Inc. (PAVM)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

PAVmed Inc. (PAVM)

PAVmed Inc. (PAVM) Q1 2026 Earnings Call Transcript

PAVmed Inc. (PAVM) Reports Q1 Loss, Lags Revenue Estimates

PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results

Will PAVmed Inc. (PAVM) Report Negative Earnings Next Week? What You Should Know

Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026

Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock

Видео

No Data

Пресс-релизы

PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results

Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock